Impact of baseline serum IL‐8 on metastatic hormone‐sensitive prostate cancer outcomes in the Phase 3 CHAARTED trial (E3805)
Harshman, Lauren C., Wang, Victoria X., Hamid, Anis A., Santone, Gabriella, Drake, Charles G., Carducci, Michael A., DiPaola, Robert S., Fichorova, Raina N., Sweeney, Christopher J.
Published in The Prostate (01.12.2020)
Published in The Prostate (01.12.2020)
Get full text
Journal Article
521 GEN-009, a personalized neoantigen vaccine candidate, elicits diverse and durable immune responses associated with clinical efficacy outcomes
Shainheit, Mara, Bicak, Ece, Golshadi, Masoud, Santone, Gabriella, Shukor, Syukri, Tjon, Emily, Xue, Li, Davis, Thomas, Flechtner, Jessica
Published in Journal for immunotherapy of cancer (01.11.2021)
Published in Journal for immunotherapy of cancer (01.11.2021)
Get full text
Journal Article
413 GEN-009, a personalized neoantigen vaccine, elicits robust immune responses in individuals with advanced or metastatic solid tumors
Shainheit, Mara, Champagne, Devin, Santone, Gabriella, Shukor, Syukri, Bicak, Ece, Tipps, Samuel, Xue, Li, Davis, Thomas, Flechtner, Jessica
Published in Journal for immunotherapy of cancer (01.11.2020)
Published in Journal for immunotherapy of cancer (01.11.2020)
Get full text
Journal Article
485 Long term results from a phase 1 trial of GEN-009, a personalized neoantigen vaccine, combined with PD-1 inhibition in advanced solid tumors
Gillison, Maura, Awad, Mark, Twardowski, Przemyslaw, Sukari, Ammar, Johnson, Melissa, Lackner, Rudy, Stein, Mark, DeCillis, Arthur, Hernandez, Richard, Price, Jessica, Mancini, Kevin, Shainheit, Mara, Santone, Gabriella, Shukor, Syukri, Bicak, Ece, Vemulapalli, Vijetha, Tjon, Emily, Flechtner, Jessica, Davis, Thomas, Cohen, Roger
Published in Journal for immunotherapy of cancer (01.11.2021)
Published in Journal for immunotherapy of cancer (01.11.2021)
Get full text
Journal Article